Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06689774 · ClinicalTrials.gov registry record · NA
Salvation Army Tobacco Quit Line Referral Implementation Trial
A NA study, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT06689774: Active NA study, sponsored by University of Wisconsin, Madison.
NCT06689774 is a NA study that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06689774, a NA study, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to understand how the Salvation Army staff can help people who use tobacco learn about and connect with no-cost treatments to help cut down or quit smoking. Researchers will gather information about the thoughts and experiences of people who smoke tobacco and receive services at the Salvation Army, as well as the experiences of the staff offering support to help treat tobacco use.
Primary Outcome
Proportion of adult Salvation Army consumers who use tobacco referred to the WTQL in any modality. Goal is at least 10% without incentives, and at least 16% with incentives.
Interventions
- BEHAVIORAL Cognitive-Motivational Feedback
- BEHAVIORAL Staff Tobacco Quit Line Referral Implementation Support
- BEHAVIORAL Consumer Incentives for Immediate Referral to a Tobacco Quit Line
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT06689774 still lists
NCT06689774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive-Motivational Feedback is the first listed.
NCT06689774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06689774 about?
NCT06689774 is a clinical study titled "Salvation Army Tobacco Quit Line Referral Implementation Trial". The goal of this clinical trial is to understand how the Salvation Army staff can help people who use tobacco learn about and connect with no-cost treatments to help cut down or quit smoking. Researchers will gather information about the thoughts and experiences of people who smoke tobacco and recei...
What is the current status of trial NCT06689774?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2024-11-01. Estimated completion is 2026-08-31.
What interventions are being tested in trial NCT06689774?
The interventions under investigation include: Cognitive-Motivational Feedback (BEHAVIORAL), Staff Tobacco Quit Line Referral Implementation Support (BEHAVIORAL), Consumer Incentives for Immediate Referral to a Tobacco Quit Line (BEHAVIORAL).
Who is sponsoring clinical trial NCT06689774?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06689774's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI